Immune responses against SARS-CoV-2 variants after two and three doses of vaccine in B-cell malignancies: UK PROSECO studySean H. Lim, David Goldblatt, Beth Stuart et al.|Nature Cancer|2022Cited by 91
Intermittent PI3Kδ inhibition sustains anti-tumour immunity and curbs irAEsSimon Eschweiler, Christian H. Ottensmeier, Lindsey Chudley et al.|Nature|2022Cited by 91